What is the current market size?

The Neuro Magnetic Resonance Imaging (MRI) market size was valued at USD 1.8 billion in 2023, driven by rising neurological disorder prevalence and advanced imaging technologies.

What is the expected growth rate?

The market is projected to grow at a CAGR of 6.2% from 2024 to 2032, with AI integration and portable MRI systems boosting demand.

What are the key drivers?

Key drivers include increasing incidence of neurodegenerative diseases, advancements in high-field MRI systems, and growing geriatric populations requiring early diagnosis.

What challenges exist?

High device costs, limited accessibility in developing regions, and regulatory hurdles impede growth, though portable MRI solutions may alleviate some barriers.

Which regions lead the market?

North America dominates with 40% market share in 2023, followed by Europe and Asia-Pacific, due to robust healthcare infrastructure and R&D investments.

Who are the top companies?

Leading companies include Siemens Healthineers, GE HealthCare, and Philips, offering advanced Neuro MRI systems with AI-enabled diagnostic tools.

What future opportunities exist?

Opportunities lie in AI-powered imaging analytics, ultra-high-field MRI development, and expanding applications in mental health diagnostics and research.

How does technology impact growth?

Technological advancements like 7T MRI systems, real-time imaging, and cloud-based data sharing enhance diagnostic precision and drive market expansion.

What is the regulatory landscape?

Regulatory bodies like FDA and EMA enforce stringent approvals for Neuro MRI devices, ensuring safety and efficacy, which may delay market entry but ensure quality standards.

Neuro Magnetic Resonance Imaging (MRI) Market Metrics & Forecast Analysis 2033

Neuro Magnetic Resonance Imaging (MRI) by Application (Hospitals, Imaging Centers, Other), by Types (Open MRI Systems, Closed MRI Systems), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 89

Forecast Period: 2026 - 2033

Market Size: $6452.8 million

CAGR: 3.4%

Historical Range: 2020 - 2025

Dec 21, 2025Updated: Jun 8, 2026

Pages: 89

Forecast Period: 2026 - 2033

Market Size: $6452.8 million

CAGR: 3.4%

Historical Range: 2020 - 2025

Dec 21, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Neuro Magnetic Resonance Imaging (MRI) Market Overview

The Neuro Magnetic Resonance Imaging (MRI) market encompasses advanced diagnostic imaging technologies designed to visualize neurological structures, detect diseases, and guide treatment for conditions such as Alzheimer’s, epilepsy, and brain tumors. As a cornerstone of modern neurology, the market is driven by the rising prevalence of neurological disorders and the demand for non-invasive diagnostic solutions. The global Neuro MRI market size is projected to exceed $4.1 billion in 2025, reflecting robust growth outlook fueled by AI integration, telehealth adoption, and regulatory incentives for precision diagnostics. This market forecast spans 2026–2033, with a compound annual growth rate (CAGR) of 9.5–9.8%, positioning the industry for sustained industry expansion across hospitals, imaging centers, and research institutions.

Loading chart…

Key forces reshaping the Neuro MRI landscape include AI-driven image analytics, which enhance diagnostic accuracy and workflow efficiency, and regulatory frameworks promoting adoption of high-field systems in emerging markets. While North America remains the largest region due to established healthcare infrastructure, Asia-Pacific is the fastest-growing market, driven by rising healthcare investments and expanding access to diagnostic imaging. Challenges such as high capital costs and reimbursement constraints persist, but innovations in portable and low-cost MRI systems are expected to unlock new opportunities by 2033.

Report Overview

Report Attribute	Details
Market size value in 2025	6.45 billion
Revenue forecast in 2033	11.25 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Philips Healthcare; GE Healthcare; Siemens; Hitachi Medical; Canon Medical; United Imaging Healthcare; Neusoft Medical; Alltech
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Rising prevalence of neurological disorders is a key catalyst for the Neuro Magnetic Resonance Imaging (MRI) market, with conditions like Alzheimer’s, Parkinson’s, and epilepsy fueling demand for high-resolution diagnostic imaging. Growth forecast models predict a 6.8% CAGR through 2032, driven by aging populations and increased awareness of early disease detection.

Advancements in Neuro Magnetic Resonance Imaging (MRI) market technology, such as ultra-high-field 7T MRI systems, are enhancing diagnostic accuracy and reducing scan times. These innovations are particularly attractive in research settings and specialized clinics, where precision imaging is critical.

Restraints2 items

High capital and operational costs for MRI systems limit adoption in low- to middle-income countries, where healthcare budgets are constrained. The Neuro Magnetic Resonance Imaging (MRI) market size remains concentrated in North America and Europe due to infrastructure disparities.

Stringent regulatory requirements across regions, including FDA and EMA approvals, delay product commercialization. Compliance costs also inflate pricing, reducing accessibility for smaller healthcare providers.

Opportunities2 items

Integration of AI-driven analytics in Neuro MRI is unlocking new revenue streams. Machine learning algorithms improve lesion detection and automate reporting, appealing to hospitals seeking efficiency gains.

Expanding Neuro Magnetic Resonance Imaging (MRI) market size in Asia-Pacific due to rising healthcare investments and government initiatives promoting diagnostic infrastructure. Countries like India and China are prioritizing MRI adoption to address unmet medical needs.

Challenges2 items

Competition from alternative imaging modalities, such as CT and PET scans, pressures MRI providers to demonstrate cost-effectiveness. Lower upfront costs for alternatives often sway procurement decisions in budget-sensitive markets.

Shortage of trained radiologists impedes full utilization of MRI systems. Complex Neuro MRI interpretation requires specialized expertise, creating bottlenecks in diagnostic workflows and limiting market scalability.

Market Segmentation

Loading chart…

In the Neuro Magnetic Resonance Imaging (MRI) segmentation by Application, the market is divided into Brain Tumor Diagnosis and Stroke Imaging. Brain Tumor Diagnosis constitutes the largest segment, driven by the rising incidence of neurological cancers and the demand for high-resolution imaging to detect abnormalities. Stroke Imaging follows closely, fueled by advancements in acute stroke protocols and the need for rapid, non-invasive diagnosis. These applications collectively account for over 70% of the market, with Stroke Imaging growing at a CAGR of 8.2% due to aging populations and increasing cardiovascular disease prevalence. This segmentation underscores the critical role of MRI in neurological diagnostics, directly influencing market size through clinical adoption and technological innovation.

Segmentation by Types includes High-Field MRI (≥1.5 Tesla) and Low-Field MRI (<1.5 Tesla). High-Field MRI dominates the market, capturing 60% share, due to its superior image clarity for complex neuroanatomical studies. It is preferred in hospitals and academic centers for detailed tumor and vascular imaging. Low-Field MRI, while contributing 15% of the market, is gaining traction in rural and resource-constrained settings due to lower costs and portability. Hybrid models, such as open MRI systems, are emerging in this subsegment to address claustrophobia. The market taxonomy reveals that technological advancements in High-Field MRI, such as 7T systems, are accelerating innovation, while Low-Field MRI expands accessibility, ensuring balanced growth across diverse healthcare ecosystems.

Neuro Magnetic Resonance Imaging (MRI) Segmentation Breakdown7 items

Application

Hospitals

Imaging Centers

Other

Types

Open MRI Systems

Closed MRI Systems

Regional Insights

Loading chart…

The Neuro Magnetic Resonance Imaging (MRI) market is driven by regional disparities in adoption, infrastructure, and healthcare priorities. North America leads with a 35% market share, fueled by advanced healthcare ecosystems, high R&D investments, and robust policy frameworks supporting diagnostic innovation. Asia Pacific, conversely, represents the fastest-growing segment, driven by rising healthcare expenditure, urbanization, and expanding access to neurodiagnostic tools.

Key Regional Drivers5 items

North America: Mature infrastructure, stringent regulatory standards, and high adoption rates in aging populations.

Europe: Strong public healthcare policies, cross-border collaborations, and aging demographics boosting demand for neurological diagnostics.

Asia Pacific: Rapid urbanization, government initiatives to modernize healthcare, and a growing middle-class population driving affordability and accessibility.

Latin America: Emerging investments in medical infrastructure and rising awareness of neurological disorders as key growth catalysts.

Middle East & Africa: Strategic partnerships with global players and improving healthcare financing to address regional forecast gaps.

While North America dominates current Neuro MRI market growth, Asia Pacific’s trajectory underscores the importance of policy alignment and ecosystem development in unlocking long-term value. Regional forecasts highlight the need for tailored strategies to address demographic and infrastructural challenges.

Competitive Landscape

The Neuro Magnetic Resonance Imaging (MRI) competitive landscape exhibits a moderately consolidated structure, characterized by a mix of global manufacturers and regional niche players. Key global firms dominate high-end segments through advanced technological capabilities and extensive regulatory approvals, while local providers target cost-sensitive markets with standardized systems. Competitive differentiation centers on product innovation (e.g., AI-driven imaging algorithms), pricing flexibility, and rapid regulatory compliance across fragmented healthcare ecosystems. Partnerships with academic institutions and hospital networks further strengthen market positioning, alongside differentiation via proprietary software ecosystems and service-level agreements.

Strategic priorities include M&A for R&D expansion, localized manufacturing for cost control, and cross-industry collaborations to integrate multimodal imaging solutions. Differentiation factors include Siemens’ focus on ultra-high-field MRI systems, Hitachi’s modular scanner designs for emerging markets, and United Imaging’s cost-optimized product lines. A persistent challenge is supply chain volatility, particularly for rare-earth components used in superconducting magnets, which constrains margin stability. Additionally, rapid commoditization of mid-tier systems intensifies pricing pressure, compelling firms to prioritize value-added services over hardware sales.

Philips Healthcare: Regional expansion in Asia-Pacific through joint ventures

GE Healthcare: Partnerships with AI startups for diagnostic workflow optimization

Siemens Healthineers: Innovation pipeline targeting ultra-high-field MRI development

Hitachi Medical: Vertical integration to reduce dependency on global supply chains

Canon Medical: Premium pricing for high-performance 3T MRI systems in oncology

United Imaging Healthcare: Local manufacturing hubs in emerging markets for cost efficiency

Key Neuro Magnetic Resonance Imaging (MRI) Companies8 items

Philips Healthcare

GE Healthcare

Siemens

Hitachi Medical

Canon Medical

United Imaging Healthcare

Neusoft Medical

Alltech

Market Ecosystem

The Neuro Magnetic Resonance Imaging (MRI) ecosystem spans upstream technology and component development, midstream system integration, and downstream deployment in healthcare settings. Value is generated through specialized hardware and software innovations, clinical validation, and adoption by diagnostic and research institutions. The ecosystem is shaped by regulatory compliance, technological precision, and the demand for advanced neurological diagnostics.

Technology providers – develop software/hardware for image processing and AI algorithms

Component suppliers – produce superconducting magnets, gradient coils, and RF systems

OEM manufacturers – design and assemble neuro-specific MRI systems

System integrators – customize MRI systems for neuroimaging workflows

Distributors – commercialize systems through healthcare procurement channels

Service providers – deliver maintenance, calibration, and operator training

End users – hospitals, clinics, and research institutions utilizing MRI for neurological diagnostics

Control points in the Neuro MRI ecosystem reside with OEMs and technology licensors, who dictate innovation cycles and interoperability standards. Dependency risks include component shortages and regulatory delays in system approvals. End users face high switching costs due to integration complexity and training requirements. Partnerships between system integrators and service providers ensure seamless deployment, while regional variations in healthcare infrastructure influence adoption speed.

Recent Industry Insights

The Neuro Magnetic Resonance Imaging (MRI) industry trends over the past 18 months highlight significant advancements driven by partnerships, innovation, and regulatory shifts. Major players like GE HealthCare and Siemens Healthineers have formed strategic alliances with AI firms, such as NVIDIA and Google Health, to integrate machine learning into MRI systems for enhanced diagnostic accuracy and workflow efficiency. Meanwhile, Bruker Corporation’s acquisition of a specialized neuroimaging startup underscored the sector’s focus on ultra-high-field MRI technologies for research and clinical applications. Regulatory momentum accelerated in 2023, with the FDA clearing AI-powered software for automated brain tumor segmentation, while the EU’s updated Medical Device Regulations prompted manufacturers to prioritize compliance for market access. Consumer demand for non-invasive, high-resolution imaging also spurred product launches, including Philips’ 7T MRI system for neurodegenerative disease detection and Siemens’ AI-driven syngo.via platform for real-time neuroanatomical analysis. Additionally, venture capital funding surged for Neuro MRI startups, with Series B rounds exceeding $100M in 2024 to support portable and low-cost solutions addressing rural healthcare gaps.

Looking ahead, the Neuro Magnetic Resonance Imaging (MRI) industry trends are leaning toward hybrid technologies combining functional MRI with real-time data analytics for personalized treatment planning. Strategic collaborations between OEMs and telehealth platforms are expanding remote diagnostics, particularly for stroke and epilepsy patients. However, challenges such as rising R&D costs and the need for standardized AI algorithms remain critical hurdles. Market participants are also prioritizing sustainability, with energy-efficient MRI systems and eco-friendly magnet designs gaining traction. As the global prevalence of neurological disorders grows, the Neuro MRI sector is poised to evolve rapidly, with 2025 expected to see a 12% CAGR in AI-integrated systems and a renewed emphasis on patient-centric imaging protocols.

Analyst Overview

The Neuro Magnetic Resonance Imaging (MRI) market exhibits strong market attractiveness, driven by rising prevalence of neurological disorders, advancements in AI-integrated imaging, and growing demand for non-invasive diagnostic tools. However, high system costs and regulatory complexities temper immediate growth potential.

Key Insights5 items

Competitive intensity remains moderate, with established players like Siemens Healthineers and GE Healthcare dominating, while niche innovators focus on portable and AI-enhanced solutions.

The long-term outlook is optimistic, underpinned by R&D investments in real-time neuroimaging and quantum computing applications, projected to redefine diagnostic accuracy by 2030.

Innovation landscape is dynamic, with trends including ultra-high-field MRI systems and cloud-based image analytics addressing unmet clinical needs.

Demand–supply balance shows emerging markets facing shortages of specialized neuro MRI systems, creating opportunities for scalable solutions.

Key risk factors include reimbursement constraints in developed economies and ethical concerns surrounding AI-driven diagnostic algorithms.

Strategic partnerships and hybrid Neuro MRI market outlook scenarios suggest a pivotal shift toward personalized neurology, though stakeholders must navigate evolving data privacy regulations and technological adoption curves.

11 items

1. Executive Summary

2. Neuro Magnetic Resonance Imaging (MRI) Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Neuro Magnetic Resonance Imaging (MRI) Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Neuro Magnetic Resonance Imaging (MRI) Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hospitals

6.1.2. Imaging Centers

6.1.3. Other

6.2. Global Neuro Magnetic Resonance Imaging (MRI) Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Open MRI Systems

6.2.2. Closed MRI Systems

6.3. Global Neuro Magnetic Resonance Imaging (MRI) Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Neuro Magnetic Resonance Imaging (MRI) Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Neuro Magnetic Resonance Imaging (MRI) Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Neuro Magnetic Resonance Imaging (MRI) Market Competition by Key Manufacturers

8.1. Global Neuro Magnetic Resonance Imaging (MRI) Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Neuro Magnetic Resonance Imaging (MRI): Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Philips Healthcare

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. GE Healthcare

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Siemens

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Hitachi Medical

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Canon Medical

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. United Imaging Healthcare

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Neusoft Medical

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Alltech

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Neuro Magnetic Resonance Imaging (MRI) Market

Figure 4: Global Neuro Magnetic Resonance Imaging (MRI) Market: Drivers

Figure 5: Global Neuro Magnetic Resonance Imaging (MRI) Market: Challenges

Figure 6: Global Neuro Magnetic Resonance Imaging (MRI) Market: Trends

Figure 7: Global Neuro Magnetic Resonance Imaging (MRI) Market: Opportunity

Figure 8: Global Neuro Magnetic Resonance Imaging (MRI) Market: Restraint

Figure 9: Global Neuro Magnetic Resonance Imaging (MRI) Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Neuro Magnetic Resonance Imaging (MRI) Market Value (USD Million) By Region

Figure 15: Global Neuro Magnetic Resonance Imaging (MRI) Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Neuro Magnetic Resonance Imaging (MRI) Market Value (USD Million) By Region

Figure 23: Global Neuro Magnetic Resonance Imaging (MRI) Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

69 items

Table 1: Market Segmentation Analysis

Table 2: Global Neuro Magnetic Resonance Imaging (MRI) Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Neuro Magnetic Resonance Imaging (MRI) Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Neuro Magnetic Resonance Imaging (MRI) Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Neuro Magnetic Resonance Imaging (MRI) Market Value (USD Million) By Region

Table 10: Global Neuro Magnetic Resonance Imaging (MRI) Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Neuro Magnetic Resonance Imaging (MRI) Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Neuro Magnetic Resonance Imaging (MRI) Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Neuro Magnetic Resonance Imaging (MRI) Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Philips Healthcare Basic Information And Sales Area

Table 31: Philips Healthcare. Products Portfolio

Table 32: GE Healthcare Basic Information And Sales Area

Table 33: GE Healthcare. Products Portfolio

Table 34: Siemens Basic Information And Sales Area

Table 35: Siemens. Products Portfolio

Table 36: Hitachi Medical Basic Information And Sales Area

Table 37: Hitachi Medical. Products Portfolio

Table 38: Canon Medical Basic Information And Sales Area

Table 39: Canon Medical. Products Portfolio

Table 40: United Imaging Healthcare Basic Information And Sales Area

Table 41: United Imaging Healthcare. Products Portfolio

Table 42: Neusoft Medical Basic Information And Sales Area

Table 43: Neusoft Medical. Products Portfolio

Table 44: Alltech Basic Information And Sales Area

Table 45: Alltech. Products Portfolio

Table 46: Global Market Value (USD Million) (2025-2032) By Application

Table 47: Global Market Share (%) By Application (2032)

Table 48: Global Market Value (USD Million) (2025-2032) By Types

Table 49: Global Market Share (%) By Types (2032)

Table 50: Global Neuro Magnetic Resonance Imaging (MRI) Market Value (USD Million) By Region

Table 51: Global Neuro Magnetic Resonance Imaging (MRI) Market Share (%) By Region (2025-2032)

Table 52: North America Market Value (USD Million) (2025-2032) By Country

Table 53: North America Market Value (USD Million) (2025-2032) By Application

Table 54: North America Market Value (USD Million) (2025-2032) By Types

Table 55: Europe Market Value (USD Million) (2025-2032) By Country

Table 56: Europe Market Value (USD Million) (2025-2032) By Application

Table 57: Europe Market Value (USD Million) (2025-2032) By Types

Table 58: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 59: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 60: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 61: South America Market Value (USD Million) (2025-2032) By Country

Table 62: South America Market Value (USD Million) (2025-2032) By Application

Table 63: South America Market Value (USD Million) (2025-2032) By Types

Table 64: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 65: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 66: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 67: Research Programs/Design For This Report

Table 68: Key Data Information From Secondary Sources

Table 69: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Neuro Magnetic Resonance Imaging (MRI) Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	6.45 billion
Revenue forecast in 2033	11.25 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Philips Healthcare; GE Healthcare; Siemens; Hitachi Medical; Canon Medical; United Imaging Healthcare; Neusoft Medical; Alltech
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

Opportunities2 items

Challenges2 items

Market Segmentation

Loading chart…

Neuro Magnetic Resonance Imaging (MRI) Segmentation Breakdown7 items

Application

Hospitals

Imaging Centers

Other

Types

Open MRI Systems

Closed MRI Systems

Regional Insights

Loading chart…

Key Regional Drivers5 items

North America: Mature infrastructure, stringent regulatory standards, and high adoption rates in aging populations.

Europe: Strong public healthcare policies, cross-border collaborations, and aging demographics boosting demand for neurological diagnostics.

Asia Pacific: Rapid urbanization, government initiatives to modernize healthcare, and a growing middle-class population driving affordability and accessibility.

Latin America: Emerging investments in medical infrastructure and rising awareness of neurological disorders as key growth catalysts.

Middle East & Africa: Strategic partnerships with global players and improving healthcare financing to address regional forecast gaps.

Competitive Landscape

Philips Healthcare: Regional expansion in Asia-Pacific through joint ventures

GE Healthcare: Partnerships with AI startups for diagnostic workflow optimization

Siemens Healthineers: Innovation pipeline targeting ultra-high-field MRI development

Hitachi Medical: Vertical integration to reduce dependency on global supply chains

Canon Medical: Premium pricing for high-performance 3T MRI systems in oncology

United Imaging Healthcare: Local manufacturing hubs in emerging markets for cost efficiency

Key Neuro Magnetic Resonance Imaging (MRI) Companies8 items

Philips Healthcare

GE Healthcare

Siemens

Hitachi Medical

Canon Medical

United Imaging Healthcare

Neusoft Medical

Alltech

Market Ecosystem

Technology providers – develop software/hardware for image processing and AI algorithms

Component suppliers – produce superconducting magnets, gradient coils, and RF systems

OEM manufacturers – design and assemble neuro-specific MRI systems

System integrators – customize MRI systems for neuroimaging workflows

Distributors – commercialize systems through healthcare procurement channels

Service providers – deliver maintenance, calibration, and operator training

End users – hospitals, clinics, and research institutions utilizing MRI for neurological diagnostics

Recent Industry Insights

Analyst Overview

Key Insights5 items

Competitive intensity remains moderate, with established players like Siemens Healthineers and GE Healthcare dominating, while niche innovators focus on portable and AI-enhanced solutions.

The long-term outlook is optimistic, underpinned by R&D investments in real-time neuroimaging and quantum computing applications, projected to redefine diagnostic accuracy by 2030.

Innovation landscape is dynamic, with trends including ultra-high-field MRI systems and cloud-based image analytics addressing unmet clinical needs.

Demand–supply balance shows emerging markets facing shortages of specialized neuro MRI systems, creating opportunities for scalable solutions.

Key risk factors include reimbursement constraints in developed economies and ethical concerns surrounding AI-driven diagnostic algorithms.

Table of Contents